125 related articles for article (PubMed ID: 27298048)
1. Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation.
Komiyama M; Shimada S; Wada H; Yamakage H; Satoh-Asahara N; Shimatsu A; Akao M; Morimoto T; Takahashi Y; Hasegawa K
J Atheroscler Thromb; 2016 Nov; 23(11):1270-1275. PubMed ID: 27298048
[TBL] [Abstract][Full Text] [Related]
2. α1-Antitrypsin low-density-lipoprotein serves as a marker of smoking-specific oxidative stress.
Wada H; Ura S; Satoh-Asahara N; Kitaoka S; Mashiba S; Akao M; Abe M; Ono K; Morimoto T; Fujita M; Shimatsu A; Takahashi Y; Hasegawa K
J Atheroscler Thromb; 2012; 19(1):47-58. PubMed ID: 22027559
[TBL] [Abstract][Full Text] [Related]
3. Effect of statins on atherogenic serum amyloid A and α1-antitrypsin low-density lipoprotein complexes.
Miyazaki Y; Katanasaka Y; Sunagawa Y; Hirano-Sunagawa S; Funamoto M; Morimoto E; Komiyama M; Shimatsu A; Satoh-Asahara N; Yamakage H; Wada H; Hasegawa K; Morimoto T
Int J Cardiol; 2016 Dec; 225():332-336. PubMed ID: 27756037
[TBL] [Abstract][Full Text] [Related]
4. Weight Gain After Smoking Cessation and Atherosclerotic Low-Density Lipoprotein Marker.
Iida M
J Atheroscler Thromb; 2016 Nov; 23(11):1257-1258. PubMed ID: 27629390
[No Abstract] [Full Text] [Related]
5. The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin-low-density lipoprotein.
Komiyama M; Wada H; Ura S; Yamakage H; Satoh-Asahara N; Shimada S; Akao M; Koyama H; Kono K; Shimatsu A; Takahashi Y; Hasegawa K
Heart Vessels; 2015 Nov; 30(6):734-9. PubMed ID: 25086816
[TBL] [Abstract][Full Text] [Related]
6. A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome.
Kotani K; Satoh N; Kato Y; Araki R; Koyama K; Okajima T; Tanabe M; Oishi M; Yamakage H; Yamada K; Hattori M; Shimatsu A;
Atherosclerosis; 2009 Jun; 204(2):526-31. PubMed ID: 19007930
[TBL] [Abstract][Full Text] [Related]
7. Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD.
Funamoto M; Sunagawa Y; Katanasaka Y; Miyazaki Y; Imaizumi A; Kakeya H; Yamakage H; Satoh-Asahara N; Komiyama M; Wada H; Hasegawa K; Morimoto T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2029-34. PubMed ID: 27616885
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A low-density lipoprotein levels and smoking status in obese Japanese patients.
Kotani K; Satoh-Asahara N; Kato Y; Araki R; Himeno A; Yamakage H; Koyama K; Tanabe M; Oishi M; Okajima T; Shimatsu A;
J Int Med Res; 2011; 39(5):1917-22. PubMed ID: 22117994
[TBL] [Abstract][Full Text] [Related]
9. Influence of atorvastatin on serum amyloid A-low density lipoprotein complex in hypercholesterolemic patients.
Kotani K; Yamada T; Miyamoto M; Ishibashi S; Taniguchi N; Gugliucci A
Pharmacol Rep; 2012; 64(1):212-6. PubMed ID: 22580538
[TBL] [Abstract][Full Text] [Related]
10. Analysis of changes on adiponectin levels and abdominal obesity after smoking cessation.
Komiyama M; Wada H; Yamakage H; Satoh-Asahara N; Sunagawa Y; Morimoto T; Ozaki Y; Shimatsu A; Takahashi Y; Hasegawa K
PLoS One; 2018; 13(8):e0201244. PubMed ID: 30086171
[TBL] [Abstract][Full Text] [Related]
11. A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease.
Ogasawara K; Mashiba S; Wada Y; Sahara M; Uchida K; Aizawa T; Kodama T
Atherosclerosis; 2004 Jun; 174(2):349-56. PubMed ID: 15136066
[TBL] [Abstract][Full Text] [Related]
12. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome.
Satoh N; Shimatsu A; Kotani K; Himeno A; Majima T; Yamada K; Suganami T; Ogawa Y
Hypertens Res; 2009 Nov; 32(11):1004-8. PubMed ID: 19763135
[TBL] [Abstract][Full Text] [Related]
13. [Development of blood examination method of serum amyloid A and LDL complex, and clinical application to prediction of cardiovascular event].
Mashiba S; Ogasawara K; Takeya M; Wada Y; Sahara M; Kojima S; Tabata K; Ueda M; Uchida K; Aizawa T; Kodama T
Rinsho Byori; 2004 Jan; 52(1):67-74. PubMed ID: 14968563
[TBL] [Abstract][Full Text] [Related]
14. Smoking cessation reduces the lectin-like low-density lipoprotein receptor index, an independent cardiovascular risk marker of vascular inflammation.
Komiyama M; Wada H; Ono K; Yamakage H; Satoh-Asahara N; Shimada S; Akao M; Morimoto T; Shimatsu A; Takahashi Y; Sawamura T; Hasegawa K
Heart Vessels; 2018 Jan; 33(1):9-16. PubMed ID: 28761986
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.
Wilson PG; Thompson JC; Webb NR; de Beer FC; King VL; Tannock LR
Am J Pathol; 2008 Dec; 173(6):1902-10. PubMed ID: 18974302
[TBL] [Abstract][Full Text] [Related]
16. Correlation between Serum Amyloid A-Low Density Lipoprotein and Genotoxicity in Smokers.
Jamil A; Rashid A; Naveed AK; Majeed A
J Coll Physicians Surg Pak; 2018 Feb; 28(2):89-92. PubMed ID: 29394964
[TBL] [Abstract][Full Text] [Related]
17. Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study.
Jylhävä J; Haarala A; Eklund C; Pertovaara M; Kähönen M; Hutri-Kähönen N; Levula M; Lehtimäki T; Huupponen R; Jula A; Juonala M; Viikari J; Raitakari O; Hurme M
J Intern Med; 2009 Sep; 266(3):286-95. PubMed ID: 19702793
[TBL] [Abstract][Full Text] [Related]
18. The effects of lifestyle modification on a new oxidized low-density lipoprotein marker, serum amyloid A-LDL, in subjects with primary lipid disorder.
Kotani K; Koibuchi H; Yamada T; Taniguchi N
Clin Chim Acta; 2009 Nov; 409(1-2):67-9. PubMed ID: 19723514
[TBL] [Abstract][Full Text] [Related]
19. The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan.
Komiyama M; Ozaki Y; Wada H; Yamakage H; Satoh-Asahara N; Morimoto T; Shimatsu A; Takahashi Y; Hasegawa K
Trials; 2018 Oct; 19(1):538. PubMed ID: 30286787
[TBL] [Abstract][Full Text] [Related]
20. Remnant-like particle cholesterol and serum amyloid A-low-density lipoprotein levels in obese subjects with metabolic syndrome.
Kotani K; Asahara-Satoh N; Kato Y; Araki R; Himeno A; Yamakage H; Koyama K; Tanabe M; Oishi M; Okajima T; Shimatsu A;
J Clin Lipidol; 2011; 5(5):395-400. PubMed ID: 21981841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
